Advertisement

Immunosuppressive effects of miscellaneous agents

  • G. L. Floersheim
Part of the Biological Council Co-ordinating Committee for Symposia on Drug Action book series (BCSDA)

Abstract

It was tempting to call this survey ‘immunosuppression by non-immunosuppressive agents’. The term immunosuppressive agent or immunosuppressant applies to a group of compounds with cytotoxic and antiproliferative properties belonging to such classes as alkylating agents, antimetabolites and antimitotics. These drugs display a general antiproliferative activity and most are used in cancer chemotherapy. They affect immune responsiveness by suppressing lymphoid tissue and its antigen-triggered proliferation. As cytotoxic drugs in cancer and as immunosuppressants in organ transplantation, autoimmune and allergic diseases, these agents have been dealt with extensively. This is also true for steroids and antilymphocyte serum, immunosuppressants that do not belong to the class of antiproliferative agents and which I shall omit from the following considerations. Traditional immunosuppressive agents such as cyclophosphamide, methotrexate, 6-mercaptopurine or azathioprine have other activities as well as immunosuppression—for example anti-inflammatory properties (Billingham et al., 1967; Turk et al., 1968; Stevens and Willoughby, 1969; Arinoviche and Loewi, 1970; Fitzgerald et al., 1971; Steinberg et al., 1972)—other compounds exert immunosuppressive side-effects.

Keywords

Free Fatty Acid Suppressor Cell Immunosuppressive Effect Experimental Allergic Encephalomyelitis Pertussis Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alivisatos, G. P., Marketos, N. and Vava, Z. (1962). Die Immunitätsparalyse bei Brucellosen. Z. Immun. forschg and Experimentelle Therapie, 122, 291Google Scholar
  2. Andersen, B. R. and Cone, R. (1974). Inhibition of human lymphocyte blast transformation by streptolysin O. J. Lab. clin. Med., 84, 241PubMedGoogle Scholar
  3. Anderson, C. B., Jaffee, B. M. and Graff, R. J. (1977). Prolongation of murine skin allografts by prostaglandin E,. Transplantation, 23, 444PubMedCrossRefGoogle Scholar
  4. Archer, B. J. (1951). Remission in rheumatoid arthritis following fever therapy with liver damage., N.Y. St. J. Med., 51, 2657Google Scholar
  5. Arinoviche, R. and Loewi, G. (1970). Comparison of the effects of two cytotoxic drugs and of antilymphocytic serum. On immune and non-immune inflammation in experimental animals. Ann. rheum. Dis., 29, 32PubMedPubMedCentralCrossRefGoogle Scholar
  6. Arnason, B. G. and Richman, D. P. (1969). Effect of oral contraceptives on experimental demyelinating disease. Archs Neurol. 21, 103CrossRefGoogle Scholar
  7. Aspinall, R. L. and Cammarata, P. S. (1969). Effect of prostaglandin E, on adjuvant arthritis. Nature, 224, 1320PubMedCrossRefGoogle Scholar
  8. Assoku, R. K. G., Tizard, I. R. and Nielsen, K. H. (1977). Free fatty acids, complement activation, and polyclonal B-cell stimulation as factors in the immunopathogenesis of African trypanosomiasis. Lancet, ii, 956CrossRefGoogle Scholar
  9. Ballantyne, D. L. and Harper, A. D. (1977). Prolongation of survival in mouse tail skin allografts by Valium (diazepam). Transplantation, 23, 163PubMedGoogle Scholar
  10. Barnes, E. W., McCuish, A. C., Loudon, N. B., Jordan, J. and Irvine, W. J. (1974) Phytohaemagglutinin - induced lymphocyte transformation and circulating autoantibodies in women taking oral contraceptives. Lancet, i, 898CrossRefGoogle Scholar
  11. Barriga, O. O. (1978). Depression of cell-mediated immunity following inoculation of Trichinella spiralis extract in the mouse. Immunology, 34, 167PubMedPubMedCentralGoogle Scholar
  12. Bendinelli, M. and Asherson, G. L. (1968). Effect of Friend virus infection on contact sensitivity. Rep. Brit. Emp. Cancer, Campgn., 45, 137Google Scholar
  13. Bennett, M. and Steeves, R. A. (1970). Immunocompetent cell functions in mice infected with Friend leukemia virus. J. Natl. Cancer Inst., 44, 1107PubMedGoogle Scholar
  14. Berenbaum, M. C. and Brown, I. N. (1964). Dose-response relationships for agents inhibiting the immune response. Immunology, 7, 65PubMedPubMedCentralGoogle Scholar
  15. Berenbaum, M. C., Fluck, P. A. and Hure, N. P. (1973). Depression of lymphocyte responses after surgical trauma. Br. J. exp. Path., 54, 597Google Scholar
  16. Billingham, M. E. J., Robinson, B. V. and Gaugas, J. M. (1967). Two antiinflammatory components in antilymphocytic serum. Nature, 214, 1138CrossRefGoogle Scholar
  17. Bloomfield, A. L. and Mateer, J. G. (1919). Changes in skin sensitiveness of tuberculin during epidemic influenza. Am. Rev. Tuberc., 3, 166Google Scholar
  18. Bollag, W. (Personal communication)Google Scholar
  19. Bomford, R. and Wedderburn, N. (1973). Depression of immune response to moloney leukaemia virus by malarial infection. Nature, 242, 471PubMedCrossRefGoogle Scholar
  20. Borel, J. F., Lazary, S. and Stahelin, H. (1974). Immunosuppressive effects of ovalicinsemicarbozone. Agents and Actions, 4, 357PubMedCrossRefGoogle Scholar
  21. Borel, J. F., Feurer, C., Gubler, H. U. and Stahelin, H. (1976). Biological effects of cyclosporin A: a new antilymphocytic agent. Agents and Actions, 6, 468PubMedCrossRefGoogle Scholar
  22. Borel, J. F., Feurer, C., Hiestand, P. C. and Stähelin, H. (1978). The effects of fractions (chalones) obtained from lymphoid organs on the immune response in vivo. Agents and Actions, 8, 523PubMedCrossRefGoogle Scholar
  23. Bottazzo, G. F., Florin-Christensen, A. and Doniach, D. (1974). Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet, ii, 1279Google Scholar
  24. Boume, H. R., Lichtenstein, L. M., Melmon, K. L., Henney, C. S., Weinstein, Y. and Shearer, G. M. (1974). Modulation of inflammation and immunity by cyclic AMP. Science, 184, 19CrossRefGoogle Scholar
  25. Bower, B. D. and Newsholme, E. A. (1978). Treatment of idiopathic polyneuritis by a polyunsaturated fatty-acid diet. Lancet, i, 583CrossRefGoogle Scholar
  26. Boyd, J. F. and Smith, A. N. (1960). The effect of compound 48/80 on the autograft and homograft reaction. Br. J. exp. Path., 41, 259Google Scholar
  27. Bradley, S. G. and Watson, D. W. (1964). Suppression by endotoxin of the immune response to actinophage in the mouse. Proc. Soc. exp. Biol. Med., 117, 570PubMedCrossRefGoogle Scholar
  28. Brock, J. and Field, E. J. (1975). Unsaturated fatty acids and transplantation. Lancet, ii, 1382Google Scholar
  29. Brodeur, B. R. and Merigan, T. C. (1974). Suppressive effect of interferon on the humoral immune response to sheep red blood cells in mice. J. Immun., 113, 1319PubMedGoogle Scholar
  30. Brody, J. A., Overfield, T. and Hammes, L. M. (1964). Depression of the tuberculin reaction by viral vaccines. New Engl. J. Med., 271, 1294PubMedCrossRefGoogle Scholar
  31. Brown, S. M., Stimmel, B., Taub, R. N., Kochwa, S. and Rosenfield, R. E. (1974). Immunologic dysfunction in heroin addicts. Archs intern. Med. 134, 1001CrossRefGoogle Scholar
  32. Buffet, R. F., Caivo, A. M. and Custer, W. A. (1978). Antiproliferative activity of highly purified mouse interferon: Brief communication. J. natn. Cancer Inst., 60, 243Google Scholar
  33. Bullock, W. E. (1968). Studies of immune mechanisms in leprosy. I. Depression of delayed allergic response to skin test antigens. New Engl. J. Med., 278, 298CrossRefGoogle Scholar
  34. Bybee, J. D. and Rogers, D. E. (1964). The phagocytic activity of polymorphonuclear leucocytes obtained from patients with diabetes mellitus. J. Lab. clin. Med., 64, 1PubMedGoogle Scholar
  35. Caine, R. Y., White, D. J. G., Rolles, K., Smith, D. P. and Herbertson, B. M. (1978). Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet, i, 1183Google Scholar
  36. Capron, A., Camus, D., Dessaint, J.-P. and Le Boubennec-Fischer, F. (1977). Altération de la réponse immune au cours des infections parasitaires. Anns d’Immunologie (Institut Pasteur), 128 C, 541Google Scholar
  37. Caraffa, C. (1932). Contributo clinico allo studio dell’allergia tuberculclinica nelle diverse fasi della pertosse. Clin. Pediat., 14, 935Google Scholar
  38. Cardon, P. V., Jr. and Gordon, R. S., Jr. (1959). Rapid increase of plasma unesterified fatty acids in man during fear. J. psychosom. Res., 4, 5PubMedCrossRefGoogle Scholar
  39. Chakrabarty, A. S. and Friedman, H. (1971). Immunosuppressive effects of incomplete Freunds’ adjuvant on hemolitic antibody-forming cells in spleens of immunized mice. J. Immun., 106, 1389PubMedGoogle Scholar
  40. Condie, R. M., Zak, S. J. and Good, R. A. (1955). Effect of meningococcal endotoxin on resistance to bacterial infection and the immune response in rabbits. Fedn. Proc., 14, 459Google Scholar
  41. Corbett, R., Bauks, K., Hinrichs, D. and Bell, T. (1975). Cellular immune responsiveness in dogs with demodectic mange. Transplant. Proc., 7, 555Google Scholar
  42. Cunningham, C. M. and Watson, D. W. (1978). Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved. Infect. Immun., 19, 470PubMedPubMedCentralGoogle Scholar
  43. Daniels, J. C., Warren, K. S. and David, J. R. (1975). Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compound Niridazole. J. Immun., 115, 1414PubMedGoogle Scholar
  44. Debré, R. and Papp, K. (1926). Sur la cuti-réaction tuberculinique du cours de la rougeole et rubéole. C. r. Soc. Biol., 95, 29Google Scholar
  45. Delbarre, F. (1975). Unsaturated fatty acid and cellular immunity. Lancet, ii, 720CrossRefGoogle Scholar
  46. De Maeyer-Guignard, J., Cachard, A. and De Maeyer, E. (1975). Delayed-type hypersensitivity to sheep red blood cells: inhibition of sensitization by interferon. Science, 190, 574PubMedCrossRefGoogle Scholar
  47. Dent, P. B., Peterson, R. D. A. and Good, R. A. (1965). A defect in cellular immunity during the incubation period of passage A leukaemia in C3H mice. Proc. Soc. exp. Biot (N. Y.), 119, 869CrossRefGoogle Scholar
  48. Dilman, V. M. (1977). Metabolic immunodepression which increases the risk of cancer. Lancet, ii, 1207CrossRefGoogle Scholar
  49. Dresser, D. W., Wortis, H. H. and Anderson, H. R. (1970). The effect of pertussis vaccine on the immune response of mice to sheep erythrocytes. Clin. exp. Immun., 7, 817.PubMedPubMedCentralGoogle Scholar
  50. Dukor, P., Salvin, S. B., Dietrich, F. M., Gelzer, J., Hess, R. and Loustalot, P. (1966). Effect of reserpine on immune reactions and tumor growth. Eur. J. Cancer, 2, 253PubMedCrossRefGoogle Scholar
  51. Fahey, J. L. and Humphrey, J. H. (1962). Effect of transplantable plasma-cell tumours on antibody response in mice. Immunology, 5, 110PubMedPubMedCentralGoogle Scholar
  52. Fernandes, G., Yunis, E. J. and Good, R. A. (1976a). Influence of diet on survival of mice. Proc. natn. Acad. Sci. U.S.A., 73, 1279CrossRefGoogle Scholar
  53. Fernandes, G., Yunis, E. J. and Good, R. A. (1976b). Suppression of adenocarcinoma by the immunological consequences of calorie restriction. Nature, 263, 504PubMedCrossRefGoogle Scholar
  54. Fidler, I. J. (1977). Depression of macrophages in mice drinking hyperchlorinated water. Nature, 270, 735PubMedCrossRefGoogle Scholar
  55. Fishel, C. W., Szentivanyi, A. and Talmage, D. W. (1964). Adrenergic factors in Bordetella pertussis- induced histamine and serotonin hypersensitivity in mice. In Bacterial endotoxins (eds. Landy, M. and Braun, W.) Rutgers University Press, New Jersey, pp. 474Google Scholar
  56. Fitzgerald, T. J., Williams, B. and Uyeki, E. M. (1971). Effects of antimitotic and anti-inflammatory agents on sodium urate-induced paw swelling in mice. Pharmacology, 6, 265.PubMedCrossRefGoogle Scholar
  57. Floersheim, G. L. (1964). Beeinflussbarkeit der Transplantationsimmunitat durch Pharmaka. Helv. physiol. Acta, 22, 241Google Scholar
  58. Floersheim, G. L. (1965a). Effect of Pertussis vaccine on the tuberculin reaction. Int. Archs Allergy, 26, 340.CrossRefGoogle Scholar
  59. Floersheim, G. L. (1965b). Pharmakologische Beeinflussbarkeit cellulärer Immunität. Z. naturwiss.- med. Grundlagenforsch., 2, 307PubMedGoogle Scholar
  60. Floersheim, G. L. (1967a). Drug-induced tolerance for skin allografts across the H-2 barrier in adult mice. Science, 156, 951PubMedCrossRefGoogle Scholar
  61. Floersheim, G. L. (1967b) Facilitation of tumor growth by Bacillus pertussis. Nature, 216, 1235PubMedCrossRefGoogle Scholar
  62. Floersheim, G. L. (1969). Suppression of cellular immunity by Gram-Negative bacteria. Antibiotica Chemother. Basel, 15, 407CrossRefGoogle Scholar
  63. Floersheim, G. L., Hopff, W. H., Gasser, M. and Bucher, K. (1971). Impairment of cell-mediated immunoresponses by Pseudomonas aeruginosa. Clin. exp. Immun., 9, 241PubMedPubMedCentralGoogle Scholar
  64. Floersheim, G. L., Borel, J. F., Wiesinger, D. and Kis, Z. (1972). Antiarthritic and Immunosuppressive effects of Pseudomonas aeruginosa. Agents and Actions, 2, 231PubMedCrossRefGoogle Scholar
  65. Folch, H. and Waksman, B. H. (1974). The splenic suppressor cell. I. Activity of Thymus-dependent adherent cells: changes with age and stress. J. Immun., 113, 127PubMedGoogle Scholar
  66. Franzl, R. E. and MacMaster, P. D. (1961). Effect of bacterial lipopolysaccharides on hemolysin formation in mice. Fedn. Proc. 20, 26Google Scholar
  67. Friedman, E. A. and Beyer, M. M. (1977). Immune competence of the streptozotocininduced diabetic rat. I. Absent second set skin allograft response. Transplantation, 24, 367PubMedCrossRefGoogle Scholar
  68. Friedman, H. and Ceglowski, W. S. (1968). Cellular basis for the immunosuppressive properties of a leukaemogenic virus. Nature, 218, 1232PubMedCrossRefGoogle Scholar
  69. Frost, P. and Lance, E. M. (1973). Abrogation of lymphocyte trapping by ascitic tumors. Nature, 246, 101PubMedCrossRefGoogle Scholar
  70. Gaugas, J. M. and Curzen, P. (1978). Polyamine interaction with pregnancy serum in suppression of lymphocyte transformation. Lancet, i, 18CrossRefGoogle Scholar
  71. Gisler, R. H., Lindhal, P. and Gresser, I. (1974). Effects of interferon on antibody synthesis in vitro. J. Immun., 113, 438PubMedGoogle Scholar
  72. Glasgow, A. H., Nimberg, R. B. Menzoian, J. O., Saporoschetz, I., Cooperband, S. R., Schmid, K. and Mannick, J. A. (1974). Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer. New EngL J. Med., 291, 1263PubMedCrossRefGoogle Scholar
  73. Goldstein, D. E., Drash, A., Gibb, J. and Blizzard, R. M. (1970). Diabetes mellitus: The incidence of circulating antibodies against chyroid, gastric and adrenal tissue. J. Pediatr. 77, 304PubMedCrossRefGoogle Scholar
  74. Goldyne, M. E. (1977). Prostaglandins and the modulation of immunological responses. Int. J. Dermatol., 16, 701PubMedCrossRefGoogle Scholar
  75. Goodwin, L. G., Green, D. G., Guy, M. W. and Voller, A. (1972). Immunosuppression during trypanosomiasis. Br. J. exp. Path., 53, 40Google Scholar
  76. Goodwin, J. S., Messner, R. P., Bankhurst, A. D., Peake, G. D., Saiki, J. H. and Williams, R. C. (1977). Prostaglandin-producing suppressor cells in Hodgkin’s disease. New Engl. J. Med. 247. 963CrossRefGoogle Scholar
  77. Green, C. J. and Allison, A. C. (1978). Extensive prolongation of rabbit Ridney allograft survival after short-term cyclosporin A treatment. Lancet, i, 1182CrossRefGoogle Scholar
  78. Greenwood, B. M. and Voller, A. (1970). Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. I. (NZB X NZW)Fl hybrid mice. Clin. exp. Immun., 8, 793Google Scholar
  79. Greenwood, B. M., Herrick, E. M. and Voller, A. (1970). Can parasitic infection suppress autoimmune disease? Proc R. Soc. Med., 63, 19PubMedPubMedCentralGoogle Scholar
  80. Greenwood, B. M., Playfair, J. H. L. and Torrigiani, G. (1971). Immunosuppression in murine malaria. I. General characteristics. Clin. exp. Immun., 8, 467PubMedPubMedCentralGoogle Scholar
  81. Greenwood, B. M., Bradley-Moore, A. M., Palit, A. and Bryceson, A. D. M. (1972). Immunosuppression in children with malaria. Lancet, i, 169Google Scholar
  82. Greenwood, B. M., Whittle, H. C. and Molyneux, D. H. (1973). Immunosuppression in African trypanosomiasis. Trans. R. Soc. trop. Med. Hyg., 67, 846.PubMedCrossRefGoogle Scholar
  83. Grob, P. J. and Harold, G. E. (1972). Immunological abnormalities and hydantoins, Br_ med. J., 2, 561PubMedPubMedCentralCrossRefGoogle Scholar
  84. Hakim, A. A. (1977). An immunosuppressive factor from serum of thermally traumatized patients. J, Trauma, 17, 908CrossRefGoogle Scholar
  85. Hanna, E. E. and Watson, D. W. (1968). Host—parasite relationships among group A streptococci. IV. Suppression of Antibody response by streptococcal pyrogenic exotoxin. J Bact., 95, 14PubMedPubMedCentralGoogle Scholar
  86. Hanna, E. E. and Watson, D. W. (1973). Enhanced immune response after immunosuppression by streptococcal pyrogenic exotoxin. Infect. Immunity, 7, 1009Google Scholar
  87. Harvey, H. A., Allegra, J. C., Demers, L. M., Luderer, J. R., Brenner, D. E., Trautlein, J. J., White, D. S., Gillin, M. A. and Lipton, A. (1977). Immunosuppression and human cancer: role of prostaglandins. Cancer, 39, 2362PubMedCrossRefGoogle Scholar
  88. Henney, C. S., Lichtenstein, L. M., Gillespie, E. and Rolley, R. T. (1973). In vivo suppression of the immune response to alloantigen by cholera enterotoxin. J. clin. Invest. 52, 2853PubMedGoogle Scholar
  89. Hersh, E. M. (1973). Immunosuppressive enzymes. Transplant. Proc., 5, 1211PubMedGoogle Scholar
  90. Hiestand, P. C., Borel, J. F., Bauer, W., Kis, Z. L., Magnee, C. and Stahelin, H. (1977). The effects of fractions (chalones) obtained from lymphoid organs on lymphocyte proliferation in vitro. Agents and Actions, 7, 327PubMedCrossRefGoogle Scholar
  91. Hirano, M., Sinkovics, J. G., Shullenberger, C. C. and Howe, C. D. (1967). Murine lymphoma: augmented growth in mice with pertussis vaccine-induced lymphocytosis. Science, 158, 1061PubMedCrossRefGoogle Scholar
  92. Hirsch, M. S., Ellis, D. A., Black, P. H., Monaco, A. P. and Wood, M. L. (1974) Immunosuppressive effects of an interferon preparation in vivo. Transplantation, 17, 234PubMedCrossRefGoogle Scholar
  93. Hopff, W. H. (1967). Makrophagenausbeute bei Kaninchen mit Cysticercen. Helv. physiol. Acta, 25, 397Google Scholar
  94. Hopff, W. H., Floersheim, G. L. and Bucher, K. (1967). Alteration der Tuberkulinreaktion durch mikrobielle Polysaccharide. Helv. physiol. Acta, 25, 1Google Scholar
  95. Howard, J. G., Scott, M. T. and Christie, G. H. (1973). Cellular mechanisms underlying the adjuvant activity of Corynebacterium parvum interactions of activated macrophages with T and B lymphocytes. In Immunopotentiation. Ciba Foundation Symposium 18, ASP (Elsevier Excerpta Medica, North-Holland) Amsterdam, p. 101Google Scholar
  96. Howard, R. J. and Simmons, R. L. (1974). Acquired immunologic deficiencies after trauma and surgical procedures. Surg. Gynecol. Obstet., 139, 771PubMedGoogle Scholar
  97. HrXak, I. and Marotti, T. (1975). Mechanism of the immunosuppressive effect of Ehrlich ascitic tumor. Eur. J. Cancer, 11, 181CrossRefGoogle Scholar
  98. Huang, S. W. and MacLaren, N. K. (1976). Insulin-dependent diabetes: a disease of autoaggression. Science, 192, 64PubMedCrossRefGoogle Scholar
  99. Hudson, K. M., Byner, C., Freeman, J. and Terry, R. J. (1976). Immunodepression, high IgM levels and evasion of the immune response in murine trypanosomiasis. Nature, 264, 256PubMedCrossRefGoogle Scholar
  100. Huldt, G., Gard, S. and Olovson, S. G. (1973). Effect of Toxoplasma gondii on the thymus. Nature, 244, 301PubMedCrossRefGoogle Scholar
  101. Hunt, C. V., Khan, W., Friedman, G. and Honck, J. C. (1977). In vitro inhibition of human peripheral blood lymphocyte transformation by an extract of Pseudomonas putida. Immunology, 33, 209PubMedGoogle Scholar
  102. Jamieson, S. W. (1976). Promethazine (Phenergan) in the treatment of rat cardiac allografts. Transplantation, 21, 69PubMedCrossRefGoogle Scholar
  103. Jayawardena, A. N. and Waksman, B. H. (1977). Suppressor cells in experimental trypanosomiasis. Nature. 265, 539PubMedCrossRefGoogle Scholar
  104. Jayawardena, A. N., Targett, G. A. T., Lenchars, E., Carter, R. L., Doenhoff, M. J. and Davies, A. J. S. (1975). T-cell activation in murine malaria. Nature, 258, 149PubMedCrossRefGoogle Scholar
  105. Jenkins, D. M., Acres, M. G., Peters, J. and Riley, J. (1972). Human chorionic gonadotropin and the fetal allograft. Am. J. Obstet. Gynec., 114, 13PubMedGoogle Scholar
  106. Jennings, J. F. and Oates, C. M. (1967). Studies on the non-specific depression of the immune response. J. exp. Med., 126, 557PubMedPubMedCentralCrossRefGoogle Scholar
  107. Johnson, A. G., Gaines, S. and Landy, M. (1956). Studies on the 0-Antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide. J. exp. Med., 103, 225PubMedPubMedCentralCrossRefGoogle Scholar
  108. Jondal, M. and Klein, G. (1973). Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J. exp. Med., 138, 1365PubMedPubMedCentralCrossRefGoogle Scholar
  109. Jones, B. M., Bird, M., Howells, M., Massey, P. R., Millar, D., Miller, J. J., Reeves, S. and Salaman, J. R. (1977). Inhibition of human mixed lymphocyte reactions by sera and urine dialysates from niridazole-treated rats. Transplantation, 24, 134PubMedCrossRefGoogle Scholar
  110. Jossifides, I. A., Gutzait, L., Brand, M. and Tocantins, L. M. (1964). Enhanced survival of skin homografts in mice with a bacterial infection. Ann. N.Y. Acad. Sci., 114, 487CrossRefGoogle Scholar
  111. Kakita, A., Blanchard, J. and Fortner, J. G. (1975). Effectiveness of prostaglandin E, and procarbazine hydrochloride in prolonging the survival of vascularized cardiac hamster-to-rat xenograft. Transplantation, 20, 439PubMedCrossRefGoogle Scholar
  112. Kamrin, B. B. (1959). Successful skin homografts in mature non-littermate rats treated with fractions containing alpha-globulins. Proc. Soc. exp. Biol. Med., 100, 58PubMedCrossRefGoogle Scholar
  113. Kantor, F. S. (1975). Infection, anergy and cell-mediated immunity. N. Engl. J. Med., 292, 629PubMedCrossRefGoogle Scholar
  114. Kappas, A., Jones, H. E. H. and Roitt, I. M. (1963). Effects of steroid sex hormones on immunological phenomena. Nature, 198, 902PubMedCrossRefGoogle Scholar
  115. Keller, R., Ogilvie, R. M. and Simpson, E. (1971). Tumour growth in nematode-infected animals. Lancet, i, 678CrossRefGoogle Scholar
  116. Kilshaw, P. J., Brent, L. and Pinto, M. (1975). Suppressor T cells in mice made unresponsive to skin allografts. Nature, 255, 489PubMedCrossRefGoogle Scholar
  117. Kirchner, H., Glaser, M. and Herberman, R. B. (1975). Suppression of cell-mediated tumour immunity by Corynebacterium parvum. Nature, 257, 396PubMedCrossRefGoogle Scholar
  118. Kleinerman, E. S., Snyderman, R. and Daniels, C. A. (1975). Depressed monocyte chemotaxis during acute influenza infection. Lancet, ii, 1063Google Scholar
  119. Krishan, S., Bhuyan, U. N., Talwar, G. P. and Ramalingaswami, V. (1974). Effect of vitamin A and protein-calorie undernutrition on immune responses. Immunology, 27, 383Google Scholar
  120. Lagrange, P. H., Mackaness, G. B., Miller, T. E. and Pardon, P. (1975). Expression of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. I. Depression of the afferent arc. II. Stimulation of the afferent arc. J. Immunol., 114, 442PubMedGoogle Scholar
  121. Landy, M., Sanderson, R. P., Bernstein, M. T. and Lerner, E. M. (1965). II Involvement of thymus in immune response of rabbits to somatic polysaccharides of Gram-negative bacteria. Science, 147, 1591PubMedCrossRefGoogle Scholar
  122. Lattime, E. C. and Strausser, H. R. (1977). Arteriosclerosis. Is stress-induced immune suppression a risk factor? Science, 198, 302PubMedCrossRefGoogle Scholar
  123. Lendrum, R., Walker, G. and Gamble, D. R. (1975). Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet, i, 880CrossRefGoogle Scholar
  124. Levene, G. M., Turk, J. L., Wright, D. J. M. and Grimble, A. G. S. (1969). Reduced lymphocyte transformation due to plasma factor in patients with active syphilis. Lancet, ii, 246CrossRefGoogle Scholar
  125. Levo, Y., Markovitz and Trainin, N. (1975). Hydantoin immunosuppression and carcinogenesis. Clin. exp. Immun., 19, 521PubMedGoogle Scholar
  126. Lichtenstein, L. M., Gillespie, E. and Bone, H. R. (1972). The effects of a series of prostaglandins on in vitro models of the allergic response and cellular immunity. Prostaglandins, 2, 519PubMedCrossRefGoogle Scholar
  127. Lyons, S. F. and Friedman, H. (1978). Cellular mechanism of cholera toxin — mediated modulation of in vitro hemolysin formation by mouse immunocytes. J. Immun., 120, 452PubMedGoogle Scholar
  128. Lurie, M. B., Harris, T. N., Abramson, S. and Allison, J. M. (1949). Constitutional factors in resistance to infection. II. The effect of estrogen on tuberculin skin sensitivity and on the allergy of the internal tissues. Am. Rev. Tuber., 59, 186Google Scholar
  129. MacCuish, A. C., Urbaniak, S. J., Campbell, C. J., Duncan, L. J. P. and Irvine, W. J. (1974). Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients. Diabetes, 23, 708PubMedCrossRefGoogle Scholar
  130. MacMaster, P. D. and Franzl, R. E. (1968). The primary immune response in mice. II. Cellular responses of lymphoid tissue accompanying the enhancement or complete suppression of antibody formation by a bacterial endotoxin. J. exp. Med., 127, 1109CrossRefGoogle Scholar
  131. Mahmoud, A. A. F. and Warren, K. S. (1974). Anti-inflammatory effects of tartaric emetic and niridazole: suppression of schistosome egg granuloma. J. Immun., 112, 222PubMedGoogle Scholar
  132. Mahmoud, A. A. F., Mandel, M. A., Warren, K. S. and Webster, L. T., Jr. (1975). Niridazole. II. A potent long acting suppressant of cellular hypersensitivity. J. Immun., 114, 279PubMedGoogle Scholar
  133. Mahmoud, A. A. F., Rodman, H. M., Mandel, M. and Warren, K. S. (1976). Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection. J. Clin. Invest. 57, 362PubMedPubMedCentralCrossRefGoogle Scholar
  134. Malakian, A. and Schwab, J. J. (1968). Immunosuppressant from group A streptococci. Science, 159, 880PubMedCrossRefGoogle Scholar
  135. Malkiel, S. and Hargis, B. J. (1964). Anaphylactic reactions in mice induced by Bordetella pertussis lipopolysaccharide. J. Allergy, 35, 306PubMedCrossRefGoogle Scholar
  136. Mangi, R. J., Niederman, J. C. and Kelleher, J. E., Jr. (1975). Depression of cell-mediated immunity during acute infectious mononucleosis. N. Engl. J. Med., 291, 1149CrossRefGoogle Scholar
  137. Mannick, J. A. and Schmid, K. (1967). Prolongation of allograft survival by an alpha-globulin isolated from normal blood. Transplantation, 5, 1231PubMedCrossRefGoogle Scholar
  138. Martin, C. M., Kunin, C. M., Gottlieb, L. S. and Finland, M. (1959). Asian Influenza A in Boston, 1957–1958. II. Severe staphylococcal pneumonia complicating influenza. Archs intern Med., 103, 532CrossRefGoogle Scholar
  139. McBride, J. S. and Micklem, H. S. (1977). Immunosuppression in murine malaria. II. The primary response to bovine serum albumin. Immunology, 33, 253PubMedPubMedCentralGoogle Scholar
  140. McCarthy, R. E. (1964). Modification of the immune response of mice to skin homografts and heterografts by Ehrlich ascites carcinoma. Cancer Res., 24, 915PubMedGoogle Scholar
  141. McGregor, I. A. and Barr, M. (1962). Antibody response to tetanus toxoid inoculation in malarious and non-malarious Gambian children. Trans. R. Soc. trop. Med. Hyg., 36, 364CrossRefGoogle Scholar
  142. McHugh, M. I., Wilkinson, R., Elliott, R. W., Field E. J., Dewar, P., Hall, R. R., Taylor, R. M. R., and Uldall, P. R. (1977). Immunosuppression with polyunsaturated fatty acids in renal transplantation. Transplantation, 24, 263PubMedCrossRefGoogle Scholar
  143. McIllmurray, M. B., Embleton, M. J., Greeves, W. G., Langman, M. J. S. and Deane, M. (1977). Controlled trial of active immunotherapy in management of stage II B malignant melanoma. Br. med. J., 1, 540PubMedPubMedCentralCrossRefGoogle Scholar
  144. Meade, C. and Mertin, J. (1976). The mechanism of immunoinhibition by arachidonic and linoleic acid: effects on the lymphoid and reticuloendothelial systems. Int. Archs. allergy appL Immun., 51, 2CrossRefGoogle Scholar
  145. Mellman, W. J. and Wetton, R. (1963). Depression of the tuberculin reaction by attenuated measles virus vaccine. J. Lab. clin. Med., 61, 453PubMedGoogle Scholar
  146. Merrit, K. and Johnson, A. G. (1965). Studies on the adjuvant action of bacterial endotoxins on antibody formation. J. Immun., 94, 416Google Scholar
  147. Mertin, J. (1976). Effect of polyunsaturated fatty acids on skin allograft survival and primary and secondary cytotoxic response in mice. Transplantation, 21, 1PubMedCrossRefGoogle Scholar
  148. Mertin, J. and Hunt, R. (1976). Influence of polyunsaturated fatty acids on survival of skin allografts and tumor incidence in mice. Proc. natn. Acad. Sci. U.S.A., 73, 928CrossRefGoogle Scholar
  149. Mertin, J., Hughes, D., Shenton, B. K. and Dickinson, J. P. (1974). In vitro inhibition by unsaturated fatty acids of the PPD- and PHA-induced lymphocyte response. Klin. Wschr. 52, 248PubMedCrossRefGoogle Scholar
  150. Mertin, J., Shenton, B. K. and Field, E. J. (1976). Unsaturated fatty acids in multiple sclerosis. Br. med. J., 2, 777CrossRefGoogle Scholar
  151. Miller, G. A. and Jackson, R. W. (1973). The effect of a Streptococcus pyrogenes teichoic acid on the immune response of mice. J. Immun., 110, 148PubMedGoogle Scholar
  152. Mitchell, A. G., Nelson, W. E. and Le Blanc, T. J. (1935). Studies in immunity. V. Effect of acute diseases on reaction of skin to tuberculin. Am. J. Dis. Child., 49, 695CrossRefGoogle Scholar
  153. Monjan, A. A. and Collector, M. I. (1977). Stress-induced modulation of the immune response. Science, 196, 307PubMedCrossRefGoogle Scholar
  154. Moroni, C. and Schumann, G. (1977). Are endogenous C-type viruses involved in the immune system? Nature, 269, 600PubMedCrossRefGoogle Scholar
  155. Mowat, A. G. and Baum, J. (1971). Chemotaxis of polymorphonuclear leucocytes from patients with diabetes mellitus. N. Engl. J. Med., 284, 621PubMedCrossRefGoogle Scholar
  156. Mowbray, J. F., Boylston, A. W., Milton, J. D. and Weksler, M. (1969). Studies on the mode of action of immunosuppressive ribonucleases. Antibiotica Chemother., 15, 384CrossRefGoogle Scholar
  157. Mueller, P. S. and Watkin, D. M. (1961). Plasma unesterified fatty acid concentrations in neoplastic disease. J. Lab, clin. Med., 57, 95Google Scholar
  158. Munoz, J. (1964). Effect of bacteria and bacterial products on anti-body response. Adv. Immunol., 4, 397CrossRefGoogle Scholar
  159. Nelken, D. (1973). Normal immunosuppressive protein (NIP). J. Immun., 110, 1161Google Scholar
  160. Nerup, J. and Binder, C. (1973). Thyroid, gastric and adrenal autoimmunity in diabetes mellitus. Acta Endocr. (Kbh), 72, 279Google Scholar
  161. Nerup, J., Andersen, O. O., Bendixen, G., Egeberg, J. and Poulsen, J. E. (1971). Antipancreatic cellular hypersensitivity in diabetes mellitus. Diabetes, 20, 424PubMedCrossRefGoogle Scholar
  162. Neter, E. (1977). Endotoxins and the immune response. Curr. topics Microbio1., 47, 82Google Scholar
  163. Nimberg, R. B., Glasgow, A. H., Menzoian, J. O., Constantin, M. B., Cooperband, S. R., Mannick, J. A. and Schmid, K. (1974). Isolation of an immunosuppressive peptide fraction from the serum of cancer patients. Cancer Res., 35, 1489Google Scholar
  164. Ninnemann, J. L., Fisher, J. C. and Frank, H. A. (1978). Prolonged survival of human skin allografts following thermal injury. Transplantation, 25, 69PubMedCrossRefGoogle Scholar
  165. Nogrady, S. G., Hartley, J. P. R. and Seaton, A. (1977). Metabolic effects of intravenous salbutamol in the course of acute severe asthma. Thorax, 32, 559PubMedPubMedCentralCrossRefGoogle Scholar
  166. Nordal, H. J., Frøland, S. S., Vandvik, B. and Norby E. (1975). Measles-virus-induced migration inhibition of human leucocytes: an immunologically unspecific phenomenon? Lancet, ii, 1266Google Scholar
  167. Odaka, T., Ishii, H., Yamanuva, K. and Yamamoto, T. (1966). Inhibitory effect of Friend leukaemia virus infection on the antibody formation to sheep erythrocytes in mice. Jap. J. exp. Med., 36, 277PubMedGoogle Scholar
  168. Old, L. J., Clarke, D. A., Benacer, B. and Goldsmith, M. (1960). The reticuloendothelial system and the neoplastic process. Ann. N.Y. Acad. Sci., 88, 264PubMedCrossRefGoogle Scholar
  169. Orbach-Arbouys, S. and Poupon, M. F. (1978). Active suppression of in vitro reactivity of spleen cells after BCG treatment. Immunology, 34, 431PubMedPubMedCentralGoogle Scholar
  170. Page, A. R., Condie, R. R. and Good, R. A. (1962). Effect of 6-mercaptopurine on inflammation. J. exp. Med, 40, 519Google Scholar
  171. Parker, C. W. and Morse, S. I. (1973). The effect of Bordetella pertussis on lymphocyte cyclic AMP and metabolism. J. exp. Med., 137, 1078PubMedPubMedCentralCrossRefGoogle Scholar
  172. Paterson, P. Y., Harvey, J. M. and Webster, L. T. (1977). Niridazole suppression of experimental allergic encephalomyelitis in Lewis rats. J. Immun., 118, 2151PubMedGoogle Scholar
  173. Pâunescu, E. (1970). In vivo and in vitro suppression of humoral and cellular immunological response by rifampicin. Nature, 228, 1118Google Scholar
  174. Pelley, R. P., Pelley, R. J., Stavitsky, A. B., Mahmoud, A. A. F. and Warren, K. S. (1975). Niridazole, a potent long-acting suppressant of cellular hypersensitivity. II. Minimal suppression of antibody responses. J. Immun., 115, 1477PubMedGoogle Scholar
  175. Peterson, R. D. A., Hendrickson, R. and Good, R. A. (1963). Reduced antibody forming capacity during the incubation period of passage A leukaemia in C3H mice. Proc. Soc. exp. Biol. (N.Y.), 114, 517PubMedCrossRefGoogle Scholar
  176. Pierpaoli, W. and Maestroni, G. J. M. (1977). Pharmacological control of the immune response by blockade of the early hormonal changes following antigen injection. Cell. Immun.. 31, 355CrossRefGoogle Scholar
  177. Piessens, W. F., Lachapelle, F. L., Legros, N. and Hennson, J. C. (1970). Facilitation of rat mammary tumor growth by BCG. Nature, 228, 1210PubMedCrossRefGoogle Scholar
  178. von Pirquet, C. E. (1908). Das Verhalten der kutanen Tuberkulinreaktion wàhrend der Masern Dtsch. med. Wschr., 34, 1297CrossRefGoogle Scholar
  179. Purtilo, D. T., Hallgrew, H. M. and Yunis, E. J. (1972). Depressed maternal lymphocyte response to phytohaemogglutinin in human pregnancy. Lancet, i, 769CrossRefGoogle Scholar
  180. Quagliata, F. and Taranta, A. (1972). Suppression of adjuvant disease by bacterial extracellular products. Ann. rheum. Dis., 31, 500PubMedPubMedCentralCrossRefGoogle Scholar
  181. Quagliata, F., Lawrence, V. J. W. and Phillips-Quagliata, J. M. (1972). Prostaglandin E, as a regulator of lymphocyte function. Selective action on B lymphocytes and synergy with procarbazine in depression of immune responses. Cell. Immun., 3, 198CrossRefGoogle Scholar
  182. Renoux, M. and Renoux, G. (1977). Brucellosis, immunosuppression and levamisole. Lancet, i, 372CrossRefGoogle Scholar
  183. Robinson, E., Sher, S. and Mekori, T. (1974). Lymphocyte Stimulation by phytohemagglutinin and tumor cells of malignant effusions. Cancer Res., 34, 1548PubMedGoogle Scholar
  184. Rose, W. C., Rodey, G. E., Rimm, A. A., Truitt, R. L. and Bortin, M. M. (1976). Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxin. Expl. Hemat., 4, 90Google Scholar
  185. Rowlands, D. T., Claman, H. N. and Kind, Phyllis D. (1965). The effect of endotoxin on the thymus of young mice. Am. J. Path. 46, 165PubMedPubMedCentralGoogle Scholar
  186. Ruckdeschel, J. C., Codish, S. D., Stranahan, A. and McKneally, M. F. (1972). Postoperative empyema improves survival in lung cancer. New EngL J. Med., 287, 1013PubMedCrossRefGoogle Scholar
  187. Ruitenberg, E. J. and Steerenberg, P. A. (1973). Possible immunosuppressive effect of Corynebacterium parvum on infection with Trichinella spiralis. Nature New Biol., 242, 149PubMedCrossRefGoogle Scholar
  188. Salaman, J. R. and Millar, D. (1975). Linoleic acid as an immunosuppressive agent. Lancet, i, 857Google Scholar
  189. Salaman M. H. (1969). Immunodepression by viruses. Antibiotica Chemother., 15, 393CrossRefGoogle Scholar
  190. Salaman, M. H., Wedderburn, N. and Bruce-Chwatt, L. J. (1969). The immunodepressive effect of a murine plasmodium and its interaction with murine oncogenic viruses. J. gen. Microbiol. 59, 383PubMedCrossRefGoogle Scholar
  191. Salaman, J. R., Bird, M., Godfrey, A. M., Jones, B., Millar, D. and Miller, J. (1977). Prolonged allograft survival with niridazole, azathioprine and prednisolone. Transplantation, 23, 29PubMedCrossRefGoogle Scholar
  192. Santiago-Delpin, E. A. and Szepsenwol, J. (1977). Prolonged survival of skin and tumour allografts in mice on high-fat diets: Brief communication. J. Nat. Cancer Inst., 59, 571Google Scholar
  193. Schwab, J. J. (1975). Suppression of the immune response by micro-organisms. Bact. Rev., 39, 121PubMedPubMedCentralGoogle Scholar
  194. Scott, M. T. (1972). Biological effects of the adjuvant Corynebacterium parvum. Inhibition of PHA, mixed lymphocyte and G-v-H reactivity. Cell. Immun., 5, 251CrossRefGoogle Scholar
  195. Siegel, B. V. and Morton, J. L. (1966). Depressed antibody response in the mouse infected with Rauscher leukaemia virus. Immunology, 10, 559PubMedPubMedCentralGoogle Scholar
  196. Silberman, S. L., Jacobs, R. P. and Cole, G. A. (1978). Mechanisms of hemopoietic and immunological dysfunction induced by lymphocytic choriomeningitis virus. Infect. Immun., 19, 533PubMedPubMedCentralGoogle Scholar
  197. Sims, F. H. and Freeman, J. W. (1966). The depression of the immune response by serum protein fractions. Immunology, 11, 175PubMedPubMedCentralGoogle Scholar
  198. Skopinska, E. (1978). The effect of lipopolysaccharide (LPS) on the development of cell-mediated immunity to transplantation antigens. Transplantation (in the press)Google Scholar
  199. Smith, J. W., Steiner, A. L. and Parker, C. W. (1971). Human lymphocyte metabolism. Effects of cyclic and non-cyclic nucleotides on stimulation by phytohemagglutinin. J. clin. Invest., 50, 442PubMedPubMedCentralCrossRefGoogle Scholar
  200. Spellman, C. W. and Daynes, R. A. (1977). Modification of immunological potential by ultraviolet radiation. Il. Generation of suppressor cells in short-term UV-irradiated mice. Transplantation, 24, 120PubMedCrossRefGoogle Scholar
  201. Stanislaysky, E. S., Bogdanova, V. V., Kirpatovsky, I. D. and Zhvanetskaya, M. I. (1977). Isolation and immunochemical characteristics of the immunosuppressive substance from Escherichia coli. J. Hyg. Epidemiol. Microbiol. Immun., 21, 84Google Scholar
  202. Starr, S. and Berkovich, S. (1967). Effect of measles gamma-globulin-modified measles and vaccine measles on the tuberculin test. New Engl. J. Med., 270, 386CrossRefGoogle Scholar
  203. Stein, M., Schiavi, R. C. and Camerino, M. (1976). Influence of brain and behaviour on the immune system. Science, 191, 435PubMedCrossRefGoogle Scholar
  204. Steinberg, A. D., Plotz, P. H., Wolff, S. M., Wong, V. G., Agus, S. G. and Decker, J. L. (1972). Cytotoxic drugs in treatment of non-malignant diseases. Ann. intern. Med., 76, 619CrossRefGoogle Scholar
  205. Stevens, J. E. and Willoughby, D. A. (1969). The antlinflammatory effect of some immuno-suppressive agents. J. Path. Bact., 97, 367CrossRefGoogle Scholar
  206. Stiles, D. P. and Erickson, R. P. (1975). Suppressive effect of seminal plasma on lymphocyte activation. Nature, 253, 727CrossRefGoogle Scholar
  207. Stimson, W. H. (1976). Studies on the immunosuppressive properties of a pregnancy-associated a-macroglobulin. Clin. exp. Immun., 25, 149Google Scholar
  208. Stjernswärd, J. (1969). Immunosuppression by carcinogens. Antibiotica Chemother. (Basel), 15, 213CrossRefGoogle Scholar
  209. Stone, H. H., Given, K. S. and Martin, J. D. (1967). Delayed rejection of skin homografts in Pseudomonas sepsis. Surg. Gynec. Obstet., 124, 1067PubMedGoogle Scholar
  210. Storb, R., Floersheim, G. L., Weiden, P. L., Graham, T. L., Kolb, H. J., Lerner, K. G., Schroeder, M. L. and Thomas, E. D. (1974). Effect of prior blood transfusions on marrow grafts abrogation of sensitization by procarbazine and antithymocyte serum. J. Immun., 112, 1508PubMedGoogle Scholar
  211. Strausser, H. R. and Bober, L. A. (1972). Inhibition of tumour growth and survival of aged mice inoculated with Moloney tumour transplants and treated with endotoxin. Cancer Res., 32, 2156PubMedGoogle Scholar
  212. Strickland, G. T., Voller, A., Pettit, L. E. and Fleck, G. D. (1972). Immunodepression associated with concomitant toxoplasma and malarial infection in mice. J. infect. Dis. 126, 54PubMedCrossRefGoogle Scholar
  213. Strom, T. B., Bear, R. A. and Carpenter, C. B.(1972). Insulin-induced augmentation of lymphocyte-mediated cytotoxicity. Science, 187, 1206CrossRefGoogle Scholar
  214. Strom, T. B., Carpenter, C. B., Garovoy, M. R., Austen, K. F., Merrill, J. P. and Kalinen, M. (1973). The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J. exp. Med, 138, 381PubMedPubMedCentralCrossRefGoogle Scholar
  215. Terry, R. J. (1978). Immunodepression in parasite infections. In Immunity in parasitic diseases. Inserm. Paris p. 161Google Scholar
  216. Ting, C. C., Tsai, S. C. and Rogers, M. J. (1977). Host control of tumor growth. Science, 197, 571PubMedCrossRefGoogle Scholar
  217. Turk, J. L. and Bryceson, A. D. M. (1971). Immunological phenomena in leprosy and related diseases. Adv. Immun., 13, 209.PubMedCrossRefGoogle Scholar
  218. Turk, J. L., Willoughby, D. A. and Stevens, J. E. (1968). An analysis of the effects of some types of antilymphocyte sera on contact hypersensitivity and certain models of inflammation. Immunology, 14, 683PubMedPubMedCentralGoogle Scholar
  219. Turnell, R. W., Clarke, L. H. and Burton, A. F. (1973). Studies on the mechanism of corticosteroid-induced lymphocytolysis. Cancer Res., 33, 203.PubMedGoogle Scholar
  220. Urquhart, G. M., Murray, M., Murray, P. K., Jennings, F. W. and Bate, E. (1973). Immunosuppression in Trypanosome brucei infections in rats and mice. Trans. R. Soc. trop. Hyg. 67, 528CrossRefGoogle Scholar
  221. Valdimarsson, H., Agnarsdottir, G. and Lachmann, P. J. (1975). Measles virus receptor on human T-lymphocytes. Nature, 225, 554CrossRefGoogle Scholar
  222. Veit, B. C. and Michael, J. G. (1969). Immune response suppression by an inhibitor in normal and immune mouse serum. Nature New BioL, 235, 238CrossRefGoogle Scholar
  223. Voller, A., Gall, D. and Manawadu, B. R. (1972). Depression of the antibody response to tetanus toxoid in mice infected with malaria parasites. Z Tropenmed. Parasit., 23, 152Google Scholar
  224. Vose, B. M. and Mondgil, G. C. (1975). Effect of surgery on tumour-directed lymphocyte responses. Br. med. J., 2, 56CrossRefGoogle Scholar
  225. Waltman, S. R., Burde, R. M. and Berrios, J. (1971). Prevention of corneal homograft rejection by oestrogens. Transplantation, 11, 194PubMedCrossRefGoogle Scholar
  226. Watson, J. D. (1975). The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis. J. exp. Med., 141, 97PubMedCrossRefGoogle Scholar
  227. Webster, L. T., Butterworth, A. E., Mahmoud, A. A. F., Mngola, E. N. and Warren, K. S. (1975). Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. New Engl. J. Med., 292, 1144PubMedCrossRefGoogle Scholar
  228. Wedderburn, N. (1974). Immunodepression produced by malarial infection in mice. In Parasites in the immunized host: mechanisms of survival. Ciba Foundation Symposium 25 ( New Series) Elsevier. Excerpta Medica. North-Holland, Amsterdam, London and New York p. 123Google Scholar
  229. Weisberg, A. S., Dancel, T. M. and Hoffman, A. (1964). Suppression of antibody synthésis and prolongation of homograft survival by chloramphenicol. J. exp. Med., 120, 183CrossRefGoogle Scholar
  230. Whang, H. Y. and Neter, E. (1967). Immunosuppression by endotoxin and its lipoid A component. Proc. Soc. exp. BioL N. Y., 124, 919CrossRefGoogle Scholar
  231. Wicher, V. and Wicher, K. (1977). In vitro cell response to Treponema pallidum infected rabbits. II. Inhibition of lymphocyte response to phytohaemagglutinin by serum of T. pallidum-infected rabbits. Clin. exp. Immun., 29, 501Google Scholar
  232. Wildstein, A., Stevens, L. E. and Hashim, G. (1976). Skin and heart allografted prolongation in tilorone-treated rats. Transplantation, 21, 129PubMedCrossRefGoogle Scholar
  233. Wilson, W. E. C., Kirkpatrick, C. H. and Talmage, D. W. (1965). Suppression of immunologic responsiveness in Uremia. Ann. intern. Med, 62, 1CrossRefGoogle Scholar
  234. Wu, C. J. and Reimann, H. A. (1931). Effect of typhus fever on intracutaneous tuberculin reaction. Nat. Med J. China, 17, 210Google Scholar
  235. Yoo, T. J., Kuo, C. Y. and Stagner, J. I. (1975). Effect of Bordetella pertussis vaccine on growth of hepatoma. Lancet, i, 402CrossRefGoogle Scholar
  236. Ziegler, J. L., Bluming, A. Z., Morrow, R. H. Jr., Cohen, M. H., Fife, E. H. Jr., Finerty, J. F. and Woods, R. (1972). Burkitt’s lymphoma and malaria. Trans. R. Soc. Trop. Hyg., 66, 285CrossRefGoogle Scholar
  237. Zimmermann, E. F., Voorting-Howking, M. and Micheal, J. G. (1977). Immunosuppression by mouse sialylated a-foetoprotein. Nature, 265, 354CrossRefGoogle Scholar
  238. Zurier, R. B. and Quagliata, F. (1971). Effect of prostaglandin E, on adjuvant arthritis. Nature, 234, 304PubMedCrossRefGoogle Scholar

Copyright information

© Institute of Biology Endowment Trust Fund 1979

Authors and Affiliations

  • G. L. Floersheim
    • 1
  1. 1.Department of DermatologyUniversitätsspital, GloriastrasseZurichSwitzerland

Personalised recommendations